Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial.

Boozer CN, Nasser JA, Heymsfield SB, Wang V, Chen G, Solomon JL.

Int J Obes Relat Metab Disord. 2001 Mar;25(3):316-24.

PMID:
11319627
2.

Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial.

Boozer CN, Daly PA, Homel P, Solomon JL, Blanchard D, Nasser JA, Strauss R, Meredith T.

Int J Obes Relat Metab Disord. 2002 May;26(5):593-604.

PMID:
12032741
5.

Multinutrient supplement containing ephedra and caffeine causes weight loss and improves metabolic risk factors in obese women: a randomized controlled trial.

Hackman RM, Havel PJ, Schwartz HJ, Rutledge JC, Watnik MR, Noceti EM, Stohs SJ, Stern JS, Keen CL.

Int J Obes (Lond). 2006 Oct;30(10):1545-56. Epub 2006 Mar 21.

PMID:
16552410
6.

Effects of a stimulant-free dietary supplement on body weight and fat loss in obese adults: a six-week exploratory study.

Woodgate DE, Conquer JA.

Curr Ther Res Clin Exp. 2003 Apr;64(4):248-62. doi: 10.1016/S0011-393X(03)00058-4.

7.
8.
9.

An acute clinical trial evaluating the cardiovascular effects of an herbal ephedra-caffeine weight loss product in healthy overweight adults.

Kalman D, Incledon T, Gaunaurd I, Schwartz H, Krieger D.

Int J Obes Relat Metab Disord. 2002 Oct;26(10):1363-6.

PMID:
12355332
10.

Effect of a dietary herbal supplement containing caffeine and ephedra on weight, metabolic rate, and body composition.

Greenway FL, De Jonge L, Blanchard D, Frisard M, Smith SR.

Obes Res. 2004 Jul;12(7):1152-7.

PMID:
15292480
11.

Dexfenfluramine treatment of obesity: a double blind trial with post trial follow up.

O'Connor HT, Richman RM, Steinbeck KS, Caterson ID.

Int J Obes Relat Metab Disord. 1995 Mar;19(3):181-9.

PMID:
7780494
12.
13.
14.

The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.

Muls E, Kolanowski J, Scheen A, Van Gaal L; ObelHyx Study Group.

Int J Obes Relat Metab Disord. 2001 Nov;25(11):1713-21.

PMID:
11753595
15.

Caffeine-herbal ephedra combination increases resting energy expenditure, heart rate and blood pressure.

Vukovich MD, Schoorman R, Heilman C, Jacob P 3rd, Benowitz NL.

Clin Exp Pharmacol Physiol. 2005 Jan-Feb;32(1-2):47-53.

PMID:
15730434
17.

Weight reduction effects of a black soy peptide supplement in overweight and obese subjects: double blind, randomized, controlled study.

Kwak JH, Ahn CW, Park SH, Jung SU, Min BJ, Kim OY, Lee JH.

Food Funct. 2012 Oct;3(10):1019-24. Epub 2012 Jun 28.

PMID:
22739624
18.

Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents.

Molnár D, Török K, Erhardt E, Jeges S.

Int J Obes Relat Metab Disord. 2000 Dec;24(12):1573-8.

PMID:
11126208
19.

The effect of an herbal dietary supplement containing ephedrine and caffeine on oxygen consumption in humans.

Greenway FL, Raum WJ, DeLany JP.

J Altern Complement Med. 2000 Dec;6(6):553-5.

PMID:
11152061
20.

Latin-American trial of orlistat for weight loss and improvement in glycaemic profile in obese diabetic patients.

Halpern A, Mancini MC, Suplicy H, Zanella MT, Repetto G, Gross J, Jadzinsky M, Barranco J, Aschner P, Ramirez L, Matos AG.

Diabetes Obes Metab. 2003 May;5(3):180-8.

PMID:
12681025
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk